Turnstone Biologics Corp. / Fundamentals

    Income statement

    Net revenue
    €0.00
    Cost of goods sold
    €0.00
    Gross profit
    €0.00
    SG&A expenses
    €14.98M
    R&D expenses
    €23.40M
    EBITDA
    -€37.66M
    D&A
    €714.59K
    EBIT
    -€38.38M
    Interest expenses
    €0.00
    EBT
    -€40.71M
    Tax expenses
    €25.03K
    Net income
    -€40.74M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €3.86M
    Changes in working capital
    -€8.67M
    Operating cash flow
    -€39.14M
    Capex
    -€17.26K
    Other investing cash flow
    €838.87K
    Net investing cash flow
    €40.10M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    -€37.97K
    Debt repayment
    €0.00
    Other financing cash flow
    -€28.48K
    Net financing cash flow
    -€28.48K
    Foreign exchange effects
    €0.00
    Net change in cash
    €929.49K
    Cash at end of period
    €16.05M
    Free cash flow
    -€39.16M

    Balance sheet

    Cash and cash equivalents
    €14.40M
    Cash and short-term investments
    €14.40M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €3.82M
    Total current assets
    €18.22M
    Property, plant & equipment
    €498.83K
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €0.00
    Total non-current assets
    €498.83K
    Total assets
    €18.22M
    Accounts payable
    €2.32M
    Short-term debt
    €354.71K
    Other current liabilities
    €2.80M
    Total current liabilities
    €5.48M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €0.00
    Total liabilities
    €5.48M
    Common stock
    €19.85K
    Retained earnings
    -€228.61M
    Other equity
    -€174.33K
    Total equity
    €12.74M
    Total liabilities and shareholders' equity
    €18.22M

    Company information

    Market capitalization
    €6.96M
    Employees
    14
    Enterprise Value
    -€12.83M

    Company ratios

    Gross margin
    0.0%
    EBITDA margin
    0.0%
    EBIT margin
    0.0%
    EBT margin
    0.0%
    Net margin
    0.0%
    ROE
    -319.7%
    ROA
    -223.6%
    Asset turnover
    0.0%
    FCF margin
    0.0%
    FCF yield
    -562.0%
    Efficiency ratio
    0.0%
    Net sales per employee
    €0.00
    Net income per employee
    -€2.91M

    Notifications